Phage-display is done using a Triton X-100 cell extract to select our clones. Nanobodies are then produced in the periplasm of E. coli, extracted using B-Per and purified using NiNTA beads exploiting the His-tag of the nanobody. These nanobodies work in IFAs. However, if these nanobodies are no eluted from the beads, but then allowed to bind to proteins of a Triton X-100 cell extract and target proteins eluted with glycine, no specific target can be identified. Can anybody spot any problems with the procedure?

More Chandra Ramakrishnan's questions See All
Similar questions and discussions